Monday - July 13, 2026
Dana-Farber Investigators Formulate First IRF Degrader with Potential for Multiple Myeloma
June 30, 2026
BOSTON, Massachusetts, June 30 [Category: BizHospital] -- The Dana-Farber Cancer Institute issued the following news release:

* * *

Dana-Farber Investigators Formulate First IRF Degrader with Potential for Multiple Myeloma

*

RESEARCH SUMMARY

Study Title: Pharmacological Targeting of IRF4 as a Therapeutic Strategy for Multiple Myeloma

Publication: Nature Chemical Biology

Dana-Farber Cancer Institute a . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products